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Abstract
Photodynamic therapy (PDT) used in combination with sonodynamic therapy 
(SDT) is a new approach that aims to increase the effectiveness of tumor treatment 
when compared to the effect of each independent therapy. PDT is based on stimulating 
sensitizers with photons, while the most accepted theory for SDT is that sensitizers are 
stimulated by the sonoluminescence phenomenon. However, after the excitation of 
the sensitizer, both therapies follow a common path, leading to the generation of free 
radicals and inducing cell death. One of the positive aspects of this combination is the 
augmentation of anti-tumor activity with fewer side effects, since cell death may be 
induced using lower sensitizer concentrations or less exposure to ultrasound or light. 
Another benefit of combining PDT and SDT, especially with the use of low-frequency 
ultrasound is the induction of sonophoresis. For instance, on the skin, it may facilitate 
the absorption of the sensitizer. However, research involving both PDT and SDT exhibit 
many variants, including differences in irradiation sources and their intensities, among 
others. These aspects contribute to a lack of standardization, leading to result variations, 
hindering assessment on the real contribution that these combined therapies can offer in 
tumor treatment. Thus, further research in the pre-clinical and clinical areas are crucial.
Keywords: cancer therapy, ultrasound, sonodynamic therapy, sonophotodynamic 
therapy, sonophoresis
1. Introduction
Currently, medicine has gone through great advances due to basic and applied 
research, as well as the implantation and discovery of new technologies. However, 
the treatment of malignant neoplasms (cancers) requires improvement. According 
to the WHO, malignant neoplasms were the second leading cause of death world-
wide in 2018 [1], and CDC estimates indicate that malignant neoplasms will be the 
main cause of death in the USA by 2030 [2].
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Malignant neoplasms are a group of diseases exhibiting the common characteristic 
of invasion of adjacent tissues by proximity or migration to other tissues and organs 
by lymphatic, blood circulation or body cavities, in a process known as metastasis. 
Malignant neoplasms exhibit six basic characteristics defined by Hannah and 
Weingberg in 2000: they are able to resist cell death, induce angiogenesis, exhibit 
replicative immortality, evade growth suppression, activate invasion (metastasis) 
and sustain proliferative signaling [3]. The origin of malignant neoplasms is still 
unknown, and several theories have been postulated in this regard, including 
Somatic Mutation theory, Evolutionary theory and Cancer Stem cell theory [4, 5]. 
Environmental factors, such as ultraviolet radiation, ionizing radiation and carcino-
gens, may alter the genetic structure of cells and explain a portion of cancer cases. To 
illustrate oncogenesis complexity, smoking is known to increase the risk for cancer up 
to 100-fold. However, when comparing the mutation numbers of lung cell carcino-
mas in smokers and non-smokers, this increase is only 1.15-fold [4]. Today, it is clear 
that the tumoral microenvironment is also part of the oncogenesis process.
Traditional cancer treatments, such as chemotherapy, radiotherapy and surgery, 
in spite of being effective for several types of tumors, saving millions of lives, are 
often aggressive, expensive and not always efficient. Chemotherapy is based on 
the use of drugs in order to reach and destroy tumor cells and radiotherapy applies 
ionizing radiation to destroy and prevent tumor growth. These therapies are the 
most common in cancer treatments, but they affect not only tumor cells but also 
healthy ones, which can lead to side effects, such as nausea and hair loss. Surgery 
can be used in several cases in which the tumor can be removed either partially or 
completely, although it can be very invasive and expensive [6]. These treatments 
are often combined to enhance results, increasing the possibility of longer remis-
sion times and, in some cases, cures. Other treatment modalities have begun to 
be recently applied, such as Immunotherapy, Hormone Therapy and Stem Cell 
Transplant, alongside, or not, traditional treatments.
Photodynamic therapy (PDT) and sonodynamic therapy (SDT) emerge as 
alternative or adjuvant treatments for cancer cases, exhibiting a minimally invasive 
approach. These therapies are based on the administration (either systemic or topi-
cal) of a photosensitizer (PS) or a sonosensitizer (SS), generally non-toxic when 
used in the appropriate concentrations, resulting in cell death when irradiated with 
light or ultrasound [7].
2. Ultrasound applied to medicine
2.1 Ultrasound in biological systems
Ultrasound is a mechanical wave exhibiting frequencies above 20 kHz, out of 
the human hearing range [8]. Historical evidence indicates that ultrasounds were 
first applied in humans to examine a brain tumor by Karl Dussik, in 1942 [9], who 
reported that, when ultrasound is focused, its biological effects are more localized 
[10]. Ultrasound applied to therapeutic purposes can be used at low intensities 
(0.125–3 W/cm2) to stimulate normal physiological responses to injury and facilitate 
the transport of substances across the skin (sonophoresis), or it can be used at high 
intensities (>5 W/cm2) to selectively destroy target tissues [11].
Acoustic cavitation occurs when ultrasound waves pass through an aqueous 
medium and it is an important ultrasound interaction with biological tissues. The dis-
turbance caused by ultrasound causes oscillations in the ambient pressure that can 
lead to gases present in the solution to form small “bubbles”. With the maintenance of 
the ultrasound waves, these bubbles may continue to increase in size and, eventually, 
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collapse (Figure 1), releasing energy [12]. Another ultrasound effect is thermal; 
where the mechanical waves cause frictional heat in tissues by molecule vibration and, 
depending on the temperature, lead to different biological effects [8]. Many factors can 
influence US treatment outcomes, such as ultrasound exposure duration, heated tissue 
volume, maximum temperature achieved and rate of temperature increases [11]. This 
effect is routinely applied in the physiotherapy area to treat osteo-muscular lesions.
2.2 Ultrasound in malignant neoplasm therapy
The first clinical application of ultrasound to malignant neoplasm was 
 performed in 1944 and, since then, several studies have been carried out applying 
this technique [13]. The consolidation of ultrasound to treat tumors originates in 
prostate neoplasm treatments that began in the 1990s, by the use of High-intensity 
focused ultrasound (HIFU), whose intensity applied to tumors may range from 100 
to 10,000 W/cm2 [14].
Almost at the same time, Yumita et al. discovered sonodynamic therapy (SDT), 
by associating hematoporphyrin derivatives (already applied in PDT) to ultrasound 
irradiation, observing cell damage up to 50% higher compared to the non-associated 
treatment [15]. Although it acts in a similar manner as PDT, the exact sonodynamic 
therapy activation mechanism of a certain molecule (sonosensitizer) is not as well 
elucidated as in photodynamic therapy. The two main hypotheses concerning SDT 
mechanisms have been postulated, both directly linked to acoustic cavitation (see 
above). The thermal effect hypothesis suggests that heat is released, leading to 
temperatures of up to 10,000 K, with pressures reaching 81 MPa after the collapse 
of cavitation bubbles, which would be responsible for sonosensitizer activation 
[16]. The second and currently widely accepted hypothesis is that sonosensitizer 
activation occurs due to an effect known as sonoluminescence, where light energy 
is released after the collapse of the cavitation microbubbles [17]. This light energy 
would be, therefore, responsible for sonosensitizer activation, which leads to the 
production of free radicals and, consequently, cell death (Figure 2) [18]. In addition 
to the use of low-intensity ultrasound as a treatment using SDT, another interesting 
feature is the possibility of facilitating the entry of molecules through the plasma 
membrane, as demonstrated by Harrison and Balcer-Kubiczek in the early 90s when 
irradiating Chinese hamster ovaries cells with low intensity ultrasound, favoring the 
entry of adriamycin and amphotericin B, evidenced by increased cell death [19]. Low 
frequency ultrasound (<100 kHz) is more efficient in increasing skin permeability 
Figure 1. 
Scheme depicturing the development of cavitation bubbles. The ultrasound waves cause the cavitation bubble to 
increase and decrease in size in sustained cycles, until the bubbles reach an unstable and critical size. When the 
bubbles implode, high temperatures and the release of energy in the form of light (Sonoluminescence) can occur.
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than therapeutic ultrasound. This is attributed to the cavitation phenomenon, which 
is more frequent at low frequencies [20]. Tachibana et al. identified that the blood 
glucose levels of hairless rats immersed in glasses containing an insulin solution 
(20 U/mL) and placed in an ultrasound bath (48 kHz) decreased by 50% in 240 min-
utes [21]. The use of ultrasound as a drug delivery mediator technique represents an 
important technological advance in many areas. This is no different in PDT treat-
ment, as it may be possible to facilitate tissue molecule entry, reducing the amount of 
sensitizers to be used in treatments, in addition to allowing a joint sonodynamic and 
photodynamic therapy effect, since both therapies work in a similar manner.
3. Sono-photodynamic therapy (SPDT) used as a combined therapy
PDT is performed in two main stages. The first comprises patient photosensitizer 
administration followed by exposing the target region of the therapy to light at an 
appropriate wavelength to produce reactive oxygen species capable of causing the 
death of microorganisms or abnormal cells, such as tumors [22]. The wavelength in 
which the photosensitizer absorbs energy is an important aspect that must be taken 
into account when choosing the sensitizer. Capella and Capella identified molecules 
that absorb light between 600 and 800 nm as ideal since, below this range, hemo-
globin, the main light-absorbing protein in the blood, would compete for the energy 
emitted to activate the photosensitizer and, above this range, photons would not 
have enough energy to participate in photochemical reactions. However, PDT exhib-
its a major limitation regarding tissue penetration [23]. Bashaktov et al. pointed 
Figure 2. 
Scheme representing the potential SDT mechanism. Ultrasound irradiation induces intracellular cavitation 
bubbles. The collapse of these bubbles, through sonoluminescence, generates an energy that will be responsible 
for the activation of the sonosensitizer from its fundamental state to an excited state. As the activated sensitizer 
returns to ground state, the released energy is then transferred to the oxygen present in the cytosol to produce 
high amounts of ROS, including oxygen peroxide and superoxide ions. These can cause several cell changes 
that may result in cell death, such as (A) oxidative degradation of lipids, that would damage cell membranes, 
organelles and vesicles that are made-up of lipids. (B) Damage to the mitochondrial membrane, initiating 
the apoptotic process mediated by cytochrome C. (C) Direct damage to structures and molecules essential for 
cellular homeostasis.
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out that skin light penetration ranges from 1.5 mm to 2.5 mm [24], and Kondo et al. 
reported that light penetration may reach 7 mm in mucous membranes [25]. In the 
light of these facts, PDT becomes limited to surface region treatments or treatments 
for surfaces located close to the irradiating source, demanding invasive techniques 
in the case of internal tissue and organ treatments. In this scenario, sonodynamic 
therapy may be an alternative, due to the ability of ultrasound to penetrate deeper 
into the organism, reaching internal tissues and organs. As a result, the combined 
use of these therapies may be extremely positive. Sono-photodynamic therapy has 
been considered more effective than the individual therapies as a possible cancer 
treatment, as verified in a glioma model [26]. The idea is to use both light and sound 
to activate a sono-photosensitizer, leading to the destruction of tumor cells. Besides 
the action of US facilitating the sensitizer cell permeability, as described previously, 
another advantage of the combined use of these two therapies is the possibility 
of reducing the sensitizer dosage without reducing treatment effects [27], since 
most assessed sonosensitizers, i.e. porphyrin derivatives, are also photosensitizers 
[28]. Some in vitro studies have already attempted to prove the effectiveness of 
this therapy. For example, Li et al. studied the effects of SPDT on C6 glioma cells 
using hematoporphyrin monomethyl ether (HMME) as a sensitizer, by ultrasound 
and light irradiation, respectively. The C6 glioma cells treated with SPDT exhib-
ited higher growth inhibition than cells treated by the individual therapies [29]. 
Furthermore, Zhu et al. used SPTD on HEPG2 cells, applying curcumin-loaded 
poly (L-lactide-co-glycolide) as a sensitizer [30]. Higher apoptosis percentages 
and better anti-cancer cell proliferation effects were observed in the group treated 
with SPDT compared to the groups submitted to either SDT or PDT. An in vivo 
study performed by Jin et al. tested the combined therapy on C3H/HeN mice, using 
ATX-70 and PH-1126 as sensitizers. The percentages of tumor inhibition observed 
in mice treated with ATX-70 were 92, 77 and 27% when submitted to SPDT, SDT 
and PDT respectively, and the group treated with the combined therapy exhibited 
an increase in 120-day survival rates to 60% in five mice, higher than in the SDT and 
PDT groups. When using PH-1126 as a sensitizer, tumor inhibition results of 98, 76, 
or 43% were observed for SPDT, SDT and PDT respectively, and the combination 
therapy increased 120-day survival rates to 88% in eight mice [27]. In addition, the 
combined therapy has also been tested in humans as summarized in Table 1. Li et 
al. evaluated seven patients with advanced gastric and esophageal adenocarcinoma 
who, after treatment with SPDT, showed improvement of the condition [31]. Wang 
et al. studied twelve patients with advanced breast carcinoma and, after treat-




7 Sensitizers applied 
sublingually, followed by 
SPDT once a week
Three patients achieved a 
complete response, three, 
a partial response and one, 
an MR response
Li et al. [31]
12 Sensitizers applied 
sublingually, followed by 
SPDT once a week
Two patients achieved a 
complete response, seven, 
a partial response and 
three, a stable disease state
Wang et al. [32]
115 Sensitizers applied 
sublingually, followed by 
SPDT once a week
Of the 115 evaluated 
patients, 70 exceeded the 
calculated life expectancy
Kenyon et al. [33]
Table 1. 
Summary of clinical research results involving SPDT.
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Kenyon et al. in a study carried out with 115 patients followed for 4 years, reported 
a significant life expectancy increase for patients diagnosed with breast, bladder, 
colorectal, prostate and ovarian cancers, among others [33]. It is important to 
standardize Sono-Photodynamic therapy experiments according to the sensitizer, 
the exposure times and light and ultrasound intensities, so that the results may be 
compared, repeated and discussed worldwide, aiming at minimally invasive appli-
cations to neoplasm treatment with minimal patient discomfort.
4. Conclusions
PDT and SDT have great potential to be used as treatments for several diseases, 
especially cancer. However, when used together (SPDT), their effects can be even 
more significant. Nonetheless there are many experimental variables that interfere 
in the outcome of the treatment. This fact leads to difficulties in comparing the 
results of assays performed by different groups around the world, either in vitro or 
in vivo. In order to appraisal the real potential of SPDT, further studies must be car-
ried out in a more standardized manner, controlling the irradiation times, intensities 
of irradiation by light and ultrasound, type of sensitizer used and even the type and 
stage of the tumor. Thus, further research in the pre-clinical and clinical areas are 
crucial. In the case of clinical studies, double blind randomized controlled trials of 
sonodynamic therapy alone and combined with photodynamic therapy are required.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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